Login to Your Account

Financings Roundup

miRagen Moves to Next Level with $20M Series B

By Catherine Shaffer
Staff Writer

Wednesday, April 25, 2012
miRagen Therapeutics Inc., of Boulder, Colo., completed a $20 million Series B financing that will help advance its unpartnered compounds toward clinical development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription